Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation.
AffiliationUCD School of Medicine and Medical Science, University College Dublin, Dublin, Ireland. firstname.lastname@example.org
Cell Line, Tumor
Data Interpretation, Statistical
Gene Knockdown Techniques
Inhibitor of Apoptosis Proteins
RNA, Small Interfering
TNF-Related Apoptosis-Inducing Ligand
X-Linked Inhibitor of Apoptosis Protein
MetadataShow full item record
CitationEffects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation. 2009, 8:39 Mol. Cancer
AbstractBACKGROUND: Manipulating apoptotic resistance represents an important strategy for the treatment of hormone refractory prostate cancer. We hypothesised that the Inhibitor of Apoptosis (IAP) Proteins may be mediating this resistance and knockdown of cIAP-1, cIAP-2 and XIAP would increase sensitivity to apoptosis. METHODS: cIAP-1, cIAP-2 and XIAP where knocked down either individually or in combination using siRNA in androgen independent prostate cancer PC-3 cells as confirmed by real-time PCR and western blotting. Cells were then treated with TRAIL, Etoposide, or Tunicamycin, and apoptosis assessed by PI DNA staining. Apoptosis was confirmed with Annexin V labelling and measurement of PARP cleavage, and was inhibited using the pan-caspase inhibitor, zVAD.fmk. Clonogenic assays and assessment of ID-1 expression by western blotting were used to measure recovery and proliferation. RESULTS: PC-3 are resistant to TRAIL induced apoptosis and have elevated expression of cIAP-1, cIAP-2 and XIAP. Combined knockdown sensitised PC-3 to TRAIL induced apoptosis, but not to Etoposide or Tunicmycin, with corresponding increases in caspase activity and PARP cleavage which was inhibited by ZVAD.fmk. Triple knock down decreased proliferation which was confirmed by decreased ID-1 expression. CONCLUSION: Simultaneous knock down of the IAPs not only sensitised the PC-3 to TRAIL but also inhibited their proliferation rates and clonogenic survival. The inability to alter sensitivity to other triggers of apoptosis suggests that this effect is specific for death receptor pathways and knock down might facilitate immune-surveillance mechanisms to counter cancer progression and, in combination with therapeutic approaches using TRAIL, could represent an important treatment strategy.
- Cellular inhibitor of apoptosis 1 (cIAP-1) degradation by caspase 8 during TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
- Authors: Guicciardi ME, Mott JL, Bronk SF, Kurita S, Fingas CD, Gores GJ
- Issue date: 2011 Jan 1
- A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.
- Authors: Dai Y, Liu M, Tang W, Li Y, Lian J, Lawrence TS, Xu L
- Issue date: 2009 Nov 6
- Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells.
- Authors: Engesæter BO, Sathermugathevan M, Hellenes T, Engebråten O, Holm R, Flørenes VA, Mælandsmo GM
- Issue date: 2011 Jul 1
- A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
- Authors: Bockbrader KM, Tan M, Sun Y
- Issue date: 2005 Nov 10
- Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.
- Authors: Yano K, Horinaka M, Yoshida T, Yasuda T, Taniguchi H, Goda AE, Wakada M, Yoshikawa S, Nakamura T, Kawauchi A, Miki T, Sakai T
- Issue date: 2011 Feb